Home・Stock List・ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Open

SectorHealthcare

79.09 -0.63

Buy Sell

Overview

Share price change

24h

Current

Min

77.72

Max

80.16

Key metrics
By Trading Economics
Income	-61K 27M
Sales	-9.6M 237M
P/E Sector Avg	20.044 64.641
EPS	1.68
Profit margin	11.551
Employees	970
EBITDA	-20M 57M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+36.15% upside

Dividends
By Acuity
Next Earnings	7 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-91M 1.8B
Previous open	79.72
Previous close	79.09

News Sentiment

By Acuity

14%

86%

19 / 340 Healthcare

ANI Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31 Jul 2026, 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30 Jul 2026, 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29 Jul 2026, 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28 Jul 2026, 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24 Jul 2026, 20:06 UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22 Jul 2026, 20:01 UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21 Jul 2026, 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20 Jul 2026, 19:46 UTC

News

Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Peer Comparison

Price change

ANI Pharmaceuticals Inc Forecast

Price Target

By TipRanks

36.15% upside

12 Months Forecast

Average 109 USD 36.15%

High 124 USD

Low 91 USD

Based on 6 Wall Street analysts offering 12 month price targets forANI Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to ANI Pharmaceuticals Inc - Dist in the past 3 months.

Sentiment

By Acuity

19 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.